Disclosed herein are cannabinoid receptor ligands of formula (I)
wherein A
1
, A
5
, R
x
, X
4
, and z are as defined in the specification. Compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and compositions are also disclosed.